Skip to main content
. 2019 Oct 28;9:15385. doi: 10.1038/s41598-019-51673-0

Table 4.

Correlations of lipid concentrations in plasma versus serum in all subjects.

Lipid r H-B Adj. p value
9,10-DiHOME 0.99 1.78E-18
9,10-DiHODE 0.99 9.18E-18
13-HODE 0.99 2.59E-15
12,13-DiHOME 0.99 3.83E-15
15,16-DiHODE 0.98 4.77E-13
19,20-DiHDoPA 0.97 1.26E-12
9-HOTE 0.97 3.93E-12
9-HODE 0.97 1.18E-11
13-HOTE 0.96 1.48E-10
12(13)-EpOME 0.96 2.04E-10
15(16)-EpODE 0.94 7.71E-09
DHA 0.93 1.60E-08
C16:1n7 0.93 3.84E-08
EPA 0.90 5.81E-07
C18:2n6 0.90 6.28E-07
C14:0 0.89 1.40E-06
AA 0.89 1.83E-06
C18:1n9 0.89 2.17E-06
C12:0 0.88 2.80E-06
DHEA 0.88 2.94E-06
C18:1n7 0.87 5.36E-06
ALA 0.87 7.22E-06
C14 Ceramide 0.87 8.78E-06
C18:3n3 0.85 2.07E-05
C20:5n3 0.84 4.24E-05
PGF2a 0.84 4.75E-05
LEA 0.84 5.45E-05
NA-Gly 0.83 9.19E-05
aLEA 0.83 9.19E-05
LA 0.82 0.0001
C16 Ceramide 0.82 0.0001
C24 dihydroceramide 0.81 0.0002
AEA 0.79 0.0005
1/2-LG 0.78 0.0008
17,18-DiHETE 0.75 0.002
C18:1 Ceramide 0.75 0.002
C24 Ceramide 0.75 0.002
C15:0 0.75 0.002
9(10)-EpOME 0.72 0.005
C18 Ceramide 0.71 0.007
1/2-AG 0.70 0.01
C17:0 0.68 0.01
11,12-DiHETrE 0.67 0.02
C16:0 0.67 0.02
4-HDoHE 0.66 0.02
C20 Ceramide 0.64 0.04
1/2-OG 0.64 0.04
C16:1n7t 0.59 ns
14,15-DiHETrE 0.59 ns
Dihomo GLA EA 0.56 ns
C20:1n9 0.55 ns
C20:2n6 0.54 ns
5-HETE 0.53 ns
12(13)-Ep-9-KODE 0.51 ns
5-HEPE 0.50 ns
DEA 0.49 ns
TXB2 0.45 ns
9c 0.44 ns
15-HETE 0.39 ns
OEA 0.37 ns
18:1 Sphingosine 0.32 ns
12-HEPE 0.31 ns
5,6-DiHETrE 0.27 ns
C20:4n6 0.25 ns
C20:3n6 0.19 ns
9,10-e-DiHO 0.13 ns
C18:0 0.12 ns
11-HETE 0.10 ns
12-HETE 0.08 ns
NO-Gly 0.04 ns
C20:0 0.04 ns
9-KODE 0.01 ns
9,10-EpO −0.27 ns
C22:4n6 # #
C22:5n3 # #
14-HDoHE # #

Pearson correlations (r) between lipid concentrations in plasma and serum samples from the total cohort (n = 22) are shown. p values were adjusted by the Holm-Bonferroni (H-B) multiple comparison test; ns, not significant (adj. p > 0.05). #Excluded due to too many missing values.